Cancer Genetics Inc
CGIX
Delayed Nasdaq - 10/20 09:59:58 pm
2.75USD
+1.85%
Upcoming events

- No events available -

Past Events
10/19/17 | 05:00pmDawson James Small Cap Growth Conference
10/05/17 | 05:00pmMarcum MicroCap Conference - One-on-One
09/27/17 | 07:30pmDisruptive Growth Company Conference
09/11/17 | 09:25pmRodman & Renshaw Global Investment Conference
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
27,0
26,9
0,55%

30,8
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-14,3
-14,5
1,0%

-7,55
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-16,7
-17,0
1,3%

-11,0
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-15,8
-17,1
7,3%

-18,6
Net income
Million $
Released
Forecast
Spread
-15,8
-17,1
7,3%

-17,6
EPS
 $
Released
Forecast
Spread
-1,00
-1,10
9,1%

-0,86
Announcement Date03/23/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
6,60
7,97
-17%

7,91
Operating income (EBITDA)
Million $
Released
Forecast
Spread



-1,91
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-3,11
-2,50
-24%

-2,67
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-2,77
-2,94
5,9%

-2,80
Net income
Million $
Released
Forecast
Spread
-2,77
-2,94
5,9%

-2,80
EPS
 $
Released
Forecast
Spread
-0,16
-0,15
-6,7%

-0,12
Announcement Date08/14/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise